FCGR3A and autoimmune disease: Thus, a better understanding of the relationship between glycosylation changes of IgG and disease activity will be helpful in the treatment and management of certain autoimmune diseases with IVIG and its (G2)2 glycoform via the saturation of FcγRIIIa, blocking FcγRIIIa-mediated ADCC (Figure 5).